Novasep has sold its U.S. subsidiary, TangenX Technology Corp., to Repligen Corp. for $39.0 million in cash. In 2006, Novasep acquired a majority stake in TangenX, located in Shrewsbury, MA. The company develops, produces and sells tangential flow filtration (TFF) technologies designed to help biomanufacturers reduce industrial purification costs of biopharmaceuticals. Its single-use TFF cassettes Sius currently has strong sales. “We are pleased to have finalized this deal with Repli...